Evidence-based treatments for human health

We are building a pipeline of evidence-based health products, through in-house development and in-licensing / partnership opportunities.

Research

Anti-Obesity

Anatara’s Anti-Obesity Program

Obesity is a medical condition of such prevalence that it is described as a new pandemic. With associated significant comorbidities and health risk factors, Anatara Lifesciences is excited to announce that it is commencing a new anti-obesity project.

The project aims to develop an oral medication to assist weight reduction and sustain weight control in conjunction with other contemporary treatments and approaches.

Research

Phase I/II IBS Clinical Trial

Irritable Bowel Syndrome (IBS) trial

Anatara Lifesciences has now concluded its human clinical trial on Irritable Bowel Syndrome (IBS).

about

Meet Anatara

INNOVATIVE SOLUTIONS FOR HUMAN HEALTH:
ANATARA LIFESCIENCES (ASX:ANR)

Anatara Lifesciences (ASX:ANR) specialises in creating evidence-based innovative products to address unmet needs in human health. Our focus is on building a pipeline of health products through development of our own proprietary technology as well as strategic partnerships. Our core commitment is to deliver tangible benefits to patients and create significant value for our shareholders.

about IBS

Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS) is the most commonly diagnosed gastrointestinal condition and a significant cost burden on health care.

11

%

Irritable Bowel Syndrome affects around 1 in 9 people

Products
& Pipelines

Developing products
for gastrointestinal health

Anatara Lifesciences is developing and commercialising innovative, evidence-based health products to address significant unmet need, with a particular focus on conditions that involve the complexity of the gastrointestinal tract

Irritable Bowel

Partnering

Latest news

Your news and information

Explore our news and information section to stay connected with our latests updates.

investor home

ASX Announcements

rewatch

Annual General Meeting 2023

investor home

Annual Reports

We’re progressing innovative,
evidence-based health solutions
Want to stay up to date with our trials and latest news?
Sign up here

All rights reserved © Anatara Lifesciences 2024